MetaADEDB 2.0 @ LMMD
erythromycin lactobionate
(NNRXCKZMQLFUPL-WBMZRJHASA-N)
Structure
SMILES
OC[C@H]([C@H]([C@@H]([C@H](C(=O)O)O)O)O[C@@H]1O[C@H](CO)[C@@H]([C@@H]([C@H]1O)O)O)O.CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2O[C@@H](C)[C@@H]([C@](C2)(C)OC)O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C[C@H](C(=O)[C@@H]([C@H]([C@]1(C)O)O)C)C)(C)O
Molecular Formula:
C49H89NO25
Molecular Weight:
1092.220
Log P:
-3.8833
Hydrogen Bond Acceptor:
26
Hydrogen Bond Donor:
14
TPSA:
411.51
CAS Number(s):
3847-29-8
Synonym(s)
1.
erythromycin lactobionate
External Link(s)
MeSHC010948
PubChem Compound71469
CHEMBLCHEMBL1200506
KEGGdr:D02009
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Biliary ColicFAERS: 1US FAERS
2Abdominal discomfortCanada Vigilance: 1Canada Vigilance
3Abdominal massOFFSIDES
4Abscess of eyelidOFFSIDES
5Acute otitis mediaOFFSIDES
6AdenitisOFFSIDES
7Alanine Aminotransferase IncreasedOFFSIDES
8Altered state of consciousnessOFFSIDES
9BlepharitisOFFSIDES
10BlepharospasmOFFSIDES
11Blood alkaline phosphatase increasedOFFSIDES
12Blood lactate dehydrogenase increasedOFFSIDES
13Chest PainOFFSIDES
14Circumstance or information capable of leading to medication errorOFFSIDES
15CyanosisOFFSIDES
16Diabetic Autonomic NeuropathyOFFSIDES
17Dyspnoea exacerbatedOFFSIDES
18Eosinophilic PneumoniaOFFSIDES
19EpilepsyOFFSIDES
20EpistaxisOFFSIDES
21Gastric ulcerOFFSIDES
22Gingival HypertrophyOFFSIDES
23Hepatic necrosisOFFSIDES
24HydronephrosisOFFSIDES
25HypercapniaOFFSIDES
26HypoxiaOFFSIDES
27Infection in an immunocompromised hostOFFSIDES
28Injection Site ReactionCanada Vigilance: 1Canada Vigilance
29Injection site painCanada Vigilance: 1Canada Vigilance
30IntubationOFFSIDES
31Joint injuryOFFSIDES
32LeukoencephalopathyOFFSIDES
33Lung AbscessOFFSIDES
34Lymphocyte stimulation test positiveOFFSIDES
35LymphomaOFFSIDES
36Mechanical ventilationOFFSIDES
37MelanosisOFFSIDES
38Mouth BreathingOFFSIDES
39NauseaCanada Vigilance: 1Canada Vigilance
40NephrolithiasisOFFSIDES
41OliguriaOFFSIDES
42PancreatitisOFFSIDES
43Pericardial effusionOFFSIDES
44PhlebitisOFFSIDES
45PruritusCanada Vigilance: 1Canada Vigilance
46Psychiatric symptomOFFSIDES
47PyonephrosisOFFSIDES
48Renal cystOFFSIDES
49Respiratory FailureOFFSIDES
50SoliloquyOFFSIDES
51Transaminases increasedOFFSIDES
52UrticariaCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120238

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.